Stephen Mullennix
2018
In 2018, Stephen Mullennix earned a total compensation of $4.3M as Chief Operating Officer and Interim Chief Financial Officer at UroGen Pharma Ltd..
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Non-Equity Incentive Plan | $223,400 |
| Option Awards | $2,552,946 |
| Salary | $359,754 |
| Stock Awards | $1,102,893 |
| Other | $575 |
| Total | $4,309,568 |
Mullennix received $2.6M in option awards, accounting for 59% of the total pay in 2018.
Mullennix also received $70K in bonus, $223.4K in non-equity incentive plan, $359.8K in salary, $1.1M in stock awards and $575 in other compensation.
Rankings
In 2018, Stephen Mullennix's compensation ranked 2,521st out of 14,244 executives tracked by ExecPay. In other words, Mullennix earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,521 out of 14,244 | 82nd |
Division Manufacturing | 929 out of 5,765 | 84th |
Major group Chemicals And Allied Products | 318 out of 2,128 | 85th |
Industry group Drugs | 258 out of 1,817 | 86th |
Industry Pharmaceutical Preparations | 201 out of 1,391 | 86th |
Source: SEC filing on April 26, 2019.
Mullennix's colleagues
We found six more compensation records of executives who worked with Stephen Mullennix at UroGen Pharma Ltd. in 2018.
2018
Ron Bentsur
UroGen Pharma Ltd.
Chief Executive Officer
2018
Gil Hakim
UroGen Pharma Ltd.
Former President
2018
Gary Titus
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Mark Schoenberg
UroGen Pharma Ltd.